Charles Chiu

Combating infectious diseases with next-generation sequencing

Apply to Attend TEDMED 2018
Join us in Palm Springs, CA at The La
Quinta Resort and Club, this Nov 14 - 16, 2018.
Apply Today!

TEDMED Talks are available, free to the world, thanks to our partners.

Share This Talk

About Charles Chiu

Infectious disease physician and clinical microbiologist Charles Chiu is the director of the University of California, San Francisco (UCSF)-Abbott Viral Diagnostics and Discovery Center, a translational research laboratory engaged in the development and validation of next-generation sequencing assays, pathogen discovery, bioinformatics software design, nanopore sequencing, and characterization of emerging infections (such as Lyme disease, enterovirus D68, and Zika virus). Next-generation sequencing can dramatically reduce the time necessary for clinical diagnosis of infections from rare, novel, or unexpected pathogens − including viruses, bacteria, fungi, and parasites, and its emergence heralds a new era in infectious disease diagnostics. Charles has authored more than 60 peer-reviewed publications, holds over 15 patents and patent applications, and serves on the scientific advisory board for Therabio, Karius, and Rubicon Genomics.

Find out more

About This Talk

Infectious disease physician and clinical microbiologist Charles Chiu is the director of the Abbott Viral Diagnostics and Discovery Center at the University of California, San Francisco. Check out Charles's 2016 TEDMED Talk to learn how next-gen sequencing is accelerating the process of diagnosing mysterious infectious diseases and helping doctors to deliver life-saving treatments.

Other Talks from TEDMED 2016